Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FFFC7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,972
Award facts
- Contract value 100% obligated
- $14,972.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,972.09 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 ml pen injectors. This firm fixed-price contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive set-aside delivery order executed under the company's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat conditions including moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making it a specialized pharmaceutical commodity within the federal medical supply chain.
This delivery order is issued as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's pharmaceutical supply portfolio supports military healthcare programs globally, encompassing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order exemplifies the operational flexibility of the prime vendor contract vehicle in fulfilling specific pharmaceutical requirements for the federal healthcare system.
Quick answers
Who was awarded contract SPE2DB25FFFC7?
SPE2DB25FFFC7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FFFC7 worth?
The government has obligated $14,972 on SPE2DB25FFFC7.
Is contract SPE2DB25FFFC7 an order under another contract?
Yes. SPE2DB25FFFC7 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFFC7 competed?
The extent of competition for SPE2DB25FFFC7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award